Tag: small molecule drug discovery market insights

  • In-Depth 2024 Small Molecule Drug Discovery Market Analysis: Growth, Share, and Emerging Trends

    In-Depth 2024 Small Molecule Drug Discovery Market Analysis: Growth, Share, and Emerging Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    2024-2033 Small Molecule Drug Discovery Market Growth Rate: What’s the Forecast?

    The market size for small molecule drug discovery has seen robust growth in the past few years. The market is projected to expand from $57.41 billion in 2023 to $63.15 billion in 2024, with a compound annual growth rate (CAGR) of 10.0%. Factors facilitating this substantial growth during the historical period include efforts towards drug repurposing, automation in the drug discovery process, a rise in investment in research & development, regulatory support for drug development, and improvements in high-throughput screening.

    The market size of small molecule drug discovery is predicted to experience a significant expansion in the forthcoming years. It is projected to escalate to a worth of $95.63 billion in 2028, with a compound annual growth rate (CAGR) of 10.9%. Factors contributing to this projected growth during the forecast period include the advent of unique therapeutic targets, drug discovery focused on patient needs, drug-device combo products, utilization of real-world evidence, integration of pharmacogenomics, and global health issues. Key trends anticipated in the forecast period comprise the introduction of fragment-based drug discovery, the application of artificial intelligence in drug discovery, RNA-focused therapeutics, cooperative ventures, advancements in drug delivery, and the acceptance of organoids and 3D cell culture models.

    Claim Your Free Sample of the Global Small Molecule Drug Discovery Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

    What Drivers Are Accelerating the Growth of the small molecule drug discovery Market?

    The upsurge in chronic disease prevalence is projected to fuel the small molecule drug discovery market’s growth. The term chronic diseases encompasses conditions lasting one year or more, disrupting daily activities, requiring consistent medical attention, or both. These conditions, including HIV, cancer, infections, heart disease, and renal disease can be addressed with small-molecule drugs. These medicines tend to be more affordable for individuals suffering from chronic diseases. As such, the increasing rate of chronic diseases is anticipated to bolster the small molecule drug discovery market. For example, a paper issued by the US-based biomedical research agency, the National Institutes of Health (NIH), in 2023 asserts that the number of Americans aged 50 and over with at least one chronic disease is estimated to surge by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. Furthermore, the count of people with multimorbidity is forecasted to ascend by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Consequently, the growing prevalence of chronic diseases is propelling the small molecule drug discovery market’s growth.

    What Key Segments Can Be Identified in the Small Molecule Drug Discovery Market?

    1) By Drug Type: Small Molecule Drugs, Biologic Drugs

    2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others

    3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others

    4) By Process/Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization

    5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

    What Trends Are On the Rise in the Small Molecule Drug Discovery Market?

    The chief trend gathering momentum in the small molecule drug discovery market is technological innovation. Prime companies active within this market are concentrating on the evolution of novel products. To illustrate, in January 2023, Dotmatics, a provider of scientific digital platforms based in the United States, introduced their Small Molecule Drug Discovery Solution. This unique design is incorporated with a scientific R&D platform that includes customizable workflows and boosted data management abilities. Consequently, it minimizes inefficient operations and hastens the transition of information from insights to decisions.

    Order Now for Fast Delivery of Your Small Molecule Drug Discovery Market Report!

    https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

    What Regions Are Steering Growth in the Small Molecule Drug Discovery Sector?

    North America was the largest region in the small molecule drug discovery market in 2023. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Small Molecule Drug Discovery Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the small molecule drug discovery market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Small Molecule Drug Discovery Market Include

    1. Small Molecule Drug Discovery Market Executive Summary

    2. Small Molecule Drug Discovery Market Segments

    3. Small Molecule Drug Discovery Market Size And Template Market Growth Rate

    4. Key Small Molecule Drug Discovery Market Trends

    5. Major Small Molecule Drug Discovery Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Small Molecule Drug Discovery Market

    26. Top Small Molecule Drug Discovery Companies

    27. Small Molecule Drug Discovery Market Opportunities And Strategies

    28. Small Molecule Drug Discovery Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Small Molecule Drug Discovery Market 2024

    5 Key Insights On The Small Molecule Drug Discovery Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Small Molecule Drug Discovery Global Market Report 2024, the small molecule drug discovery market is expected to show significant growth in the forecast period.

    The small molecule drug discovery market has witnessed robust growth in recent years, with a notable increase from $57.41 billion in 2023 to an anticipated $63.15 billion in 2024, boasting a compound annual growth rate (CAGR) of 10.0%. This growth trajectory can be attributed to various factors, including drug repurposing initiatives, automation, increased R&D investment, regulatory support, and advancements in high-throughput screening.

    Anticipated Growth Trajectory

    The market is expected to continue its rapid growth, reaching $95.63 billion by 2028, with a CAGR of 10.9%. The forecasted growth is fueled by the emergence of novel therapeutic targets, patient-centric drug discovery, drug-device combination products, real-world evidence utilization, pharmacogenomics integration, and addressing global health challenges.

    Chronic Disease Surge Propels Market Growth

    – Impact of Chronic Diseases

    The surge in chronic diseases globally acts as a significant driver for the small molecule drug discovery market. With conditions such as HIV, cancer, infections, heart disease, and renal disease on the rise, small molecule medications offer cost-effective solutions for chronic disease management.

    – Statistical Insights

    According to the National Institutes of Health (NIH), the United States is expected to witness a 99.5% increase in the population aged 50 and older with at least one chronic illness by 2050. This demographic shift underscores the importance of small molecule drug discovery in addressing the healthcare needs of aging populations.

    View More On The Small Molecule Drug Discovery Market Report 2024 – https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

    Technological Innovations Drive Market Dynamics

    – Embracing Technological Advancements

    Technological innovations emerge as a central trend in the small molecule drug discovery market. Companies are focusing on developing new products, such as Dotmatics’ Small Molecule Drug Discovery Solution, which integrates pre-configured workflows and expanded data management capabilities to enhance operational efficiency and accelerate decision-making processes.

    Strategic Acquisitions Shape the Landscape

    – GSK’s Acquisition of Sierra Oncology

    In July 2022, GSK Plc. acquired Sierra Oncology Inc. for $1.9 billion, fortifying its cancer treatment portfolio and innovation pipeline. Sierra Oncology’s expertise in targeted therapeutics complements GSK’s commitment to enhancing patient outcomes and innovation in cancer treatment modalities.

    Segmenting the Small Molecule Drug Discovery Market

    – By Drug Type

    The market is segmented by drug type, including small molecule drugs and biologic drugs, catering to diverse therapeutic needs.

    – By Technology

    Technological advancements such as high throughput screening, pharmacogenomics, combinatorial chemistry, nanotechnology, and others drive innovation in drug discovery processes.

    – By Therapeutic Area

    Segmentation by therapeutic area includes oncology, central nervous system, cardiovascular, respiratory, metabolic disorders, gastrointestinal, and other therapeutic areas, addressing a wide spectrum of medical needs.

    – By Process/Phase

    The market also segments by process/phase, covering target ID or validation, hit generation and selection, lead identification, and lead optimization stages in the drug discovery pipeline.

    – By End-User

    End-users encompass pharmaceutical companies, contract research organizations, and other stakeholders involved in drug discovery and development processes.

    Regional Insights

    North America led the small molecule drug discovery market in 2023, with Europe expected to exhibit the fastest growth during the forecast period, highlighting the global nature of drug discovery efforts.

    In conclusion, the small molecule drug discovery market thrives on innovation, technological advancements, and strategic collaborations. As companies navigate through evolving healthcare landscapes and rising disease burdens, innovation remains paramount in driving positive patient outcomes and shaping the future of drug discovery.

    Request A Sample Of The Global Small Molecule Drug Discovery Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9834&type=smp